Head-to-head · WeighScore
boostAGErx vs Corsica Health
The verdict
boostAGErx takes it — 66.8/100 to 66.3/100, but only just.
boostAGErx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. boostAGErx is a longevity-focused telehealth brand offering compounded GLP-1 weight management (semaglutide and tirzepatide) starting around $95/mo on a 12-month upfront plan, plus peptide therapy such as… Corsica Health is close behind and may still be the better fit — see the factor split below.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | boostAGErx | Corsica Health |
|---|---|---|
| WeighScore | 66.8/100 | 66.3/100 |
| Grade | C | C |
| Scorecard rank | #183 | #193 |
| Semaglutide | $95/mo (starting dose, compounded) | $249/mo (compounded) |
| Tirzepatide | $95/mo (starting dose, compounded) | $349/mo (compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Injection only | Injection only |
Graded #183 · C
Strengths
- Compounded GLP-1 starting around $95/mo (12-month plan paid upfront)
- Free shipping and clinical evaluation included
- Membership fee refunded in full if you're not approved
- Also offers peptide therapy such as sermorelin
- 100% online with licensed providers — no clinic visit
Where it loses points
- Headline $95/mo requires a 12-month upfront commitment; actual price varies by product/plan
- Compounded medications are non-refundable once dispensed
- Pharmacy partner not named on the site
- Not LegitScript-certified (no certification displayed)
- States of operation not published
Graded #193 · C
Strengths
- Public pricing shown for both compounded and brand-name options — a real transparency advantage
- $1,499/mo brand-name Wegovy/Ozempic/Mounjaro is below typical retail cash-pay
- LegitScript Certified
- Clear 3-step intake: Assessment, Provider Review, Receive Medication
- $199/mo compounded semaglutide and $249/mo compounded tirzepatide (3-month plans) are competitively priced
Where it loses points
- Legal entity name and state of incorporation not disclosed on the site
- Pharmacy partner described only as a 'licensed compounding pharmacy,' not named
- Per-state availability not listed publicly
- First-month promotional pricing not disclosed
- Lab-work inclusion not clearly disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.